IP Verse

Crastalline Hydrobromide Salt Of 5-Meo-Dmt - EP4313945

The patent EP4313945 was granted to GH Research Ireland on Mar 13, 2024. The application was originally filed on Mar 27, 2023 under application number EP23717046A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4313945

GH RESEARCH IRELAND
Application Number
EP23717046A
Filing Date
Mar 27, 2023
Status
Granted And Under Opposition
Feb 9, 2024
Grant Date
Mar 13, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

SCORPIODec 4, 2024SAGITTARIUSADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO2020169850
DESCRIPTIONWO2020169851
DESCRIPTIONWO2020254584
DESCRIPTIONWO2021250434
DESCRIPTIONWO2021250435
INTERNATIONAL-SEARCH-REPORTWO2021250435
INTERNATIONAL-SEARCH-REPORTWO2023002005
OPPOSITIONWO2021250435
OTHERWO2021250435

Non-Patent Literature (NPL) Citations (10) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Anonymous, "Introduction and Chapter 6: “X-ray Mirrors”", X’Pert PRO X-ray Diffraction System; User’s Guide; Sixth Edition, Almelo, PANalytical B.V., (20070327), pages 6.1 - 6.36, XP009561769-
OPPOSITION- D6 - T777/08-
OPPOSITION- D7 - Annex for EP4313945 - data from salt and polymorph screens: 5- MeO-DMT-
OPPOSITION- Michael E. Aulton, "Chapter 2: Dissolution and solubility: Part 1: Scientific principles of dosage form design", Aulton's Pharmaceutics, Edinburgh, Elsevier, (20180101), pages 18 - 36, ISBN 978-0-7020-7003-7, XP093154484-
OPPOSITION- REGISTRY, (20220303), Database accession no. 2761182-82-3, XP093279015-
OPPOSITION- Michael M. Woolfson, "3 Diffraction from a crystal", Michael M. Woolfson, Michael M. Woolfson, An Introduction to X-ray Crystallography, Second Edition, Cambridge University Press, (19970101), pages 50 - 75, doi:10.1017/CBO9780511622557, ISBN 0-521-41271-4, XP009561771
OPPOSITION- MICHAEL M. WOOLFSON, "6 The factors affecting X-ray intensities", MICHAEL M. WOOLFSON, MICHAEL M. WOOLFSON, An Introduction to X-ray Crystallography, Second Edition, Cambridge University Press, (19970101), pages 156 - 189, doi:10.1017/CBO9780511622557, ISBN 0-521-41271-4, XP009561770
OPPOSITION- Stephen Byrn; Pfeiffer Ralph; Ganey Michael; Hoiberg Charles; Poochikian Guirag, "Pharmaceutical Solids: A strategic Approach to Regulatory Considerations", Pharmaceutical Research, Springer Berlin Heidelberg, Berlin/Heidelberg, Berlin/Heidelberg, (19950701), vol. 12, no. 07, doi:10.1023/A:1016241927429, ISSN 0724-8741, pages 945 - 954, XP000996386
OPPOSITION- Jurczak Ewa, Mazurek Anna Helena, Szeleszczuk Łukasz, Pisklak Dariusz Maciej, Zielińska-Pisklak Monika, "Pharmaceutical Hydrates Analysis—Overview of Methods and Recent Advances", Pharmaceutics, vol. 12, no. 10, doi:10.3390/pharmaceutics12100959, page 959, XP055802485
OPPOSITION- Hermann Otto Hans, "X-Ray Powder Diffraction: Why Not Use CuKβ Radiation?", Journal of Analytical Sciences, Methods and Instrumentation, (20180101), vol. 08, no. 03, doi:10.4236/jasmi.2018.83004, ISSN 2164-2745, pages 37 - 47, XP093279014

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents